What's going on here lately?

Discussion in 'Heron Therapeutics' started by anonymous, Oct 6, 2016 at 5:48 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    What happened with the 3 execs?
     

  2. anonymous

    anonymous Guest

    Please tell us more what 3 exec's
     
  3. anonymous

    anonymous Guest

    Neil Clendeninn, Ph.D., SVP, Chief Medical Officer and Paul Marshall, SVP, Technical Operations resigned September 30. Brian Drazba, VP, Finance and CFO, will resign effective March 31, 2017.
     
  4. anonymous

    anonymous Guest

    Heron Therapeutics (NASDAQ: HRTX) is under heavy pressure Monday (-10.6%) after the company disclosed late Friday it has accepted the resignations of Neil J. Clendeninn, M.D., Ph.D., the Company’s Senior Vice President, Chief Medical Officer, Paul G. Marshall, the Company’s Senior Vice President, Technical Operations, and Brian G. Drazba, the Company’s Vice President, Finance and Chief Financial Officer. The resignations of Dr. Clendeninn and Mr. Marshall are effective as of September 30, 2016.

    Heron said they will each be eligible to receive a one-time severance payment equal to their respective 2016 annual salary, plus the 2016 annual bonus payment for Dr. Clendeninn and the average annual bonus paid over the prior three years for Mr. Marshall, and certain additional severance benefits.

    The resignation of Mr. Drazba will be effective as of March 31, 2017, at which time he will be eligible to receive a one-time severance payment equal to his 2016 annual salary and his average annual bonus paid over the prior three years, as well as certain additional severance benefits.
     
  5. anonymous

    anonymous Guest

    It's a shame that the sales reps and other field based people are going to get hurt here. It's not their fault, even though one could say they should have asked their accounts a bit more about their willingness to use a pipe to inject a sludgy formulation under the skin when a line is already open for the chemo.

    But putting that aside, it's simply bad business acumen to expect a crappy product with ZERO benefits vs. existing competition and a meager buy-and-bill contract to do well. Mr. Tang should have cut his losses years ago. But ego and the chance to pump up the stock and then sell the company with an FDA approved drug and a validated delivery platform was probably just too enticing. So he plowed more and more money into the pit.

    Heron's story may well end up as a business school case study, with the moral being Know When to Throw in the Towel.
     
  6. anonymous

    anonymous Guest

    The problem with Heron Therapuetics all goes back to the guy who has destroyed every company he's worked at. If you want to know the reason for these people being fired. Take a look at Rob Rosen's past and ask any customer or employee what they think of him. I heard he is the new CEO?
     
  7. anonymous

    anonymous Guest

    HATERS GONNA HATE. this post should be deleted 4 misinformation. but who cares most neg nancies are either shorts or waste 2nd rate sales reps. BUSY TIMES AHEAD... TANG+QUART WILL ROAST SHORTS.
     
  8. anonymous

    anonymous Guest

    let's go drink a quart of tang!
     
  9. anonymous

    anonymous Guest

    Haters? What is there to hate? Am I supposed to be jealous of your shitty leadership? Or your shitty contracts? Or your shitty product? That kool-aid must be real good. RR is delusional and psychotic. Everyone knows he's a pathetic loose cannon who's not respected. His sad fantasy is to be feared, I guess he had a bad childhood... He thinks people laugh with him but they ALL laugh AT him behind his back. Here's the real deal: say what they want, but the facts don't lie. In Q1 let me know who is hating. Actually, you won't have to because the $ will be public knowledge. The only people hating will be those who are stuck in the sinking ship with Captain Rotten Rosen.
     
  10. anonymous

    anonymous Guest

    wow your panties are in a knot